Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species

Access this Article

Abstract

Ebola virus (EBOV), which belongs to the genus Ebolavirus, causes a severe and often fatal infection in primates, including humans, whereas Reston virus (RESTV) only causes lethal disease in non-human primates. Two amino acids (aa) at positions 82 and 544 of the EBOV glycoprotein (GP) are involved in determining viral infectivity. However, it remains unclear how these two aa residues affect the infectivity of Ebolavirus species in various hosts. Here we performed viral pseudotyping experiments with EBOV and RESTV GP derivatives in 10 cell lines from 9 mammalian species. We demonstrated that isoleucine at position 544/545 increases viral infectivity in all host species, whereas valine at position 82/83 modulates viral infectivity, depending on the viral and host species. Structural modelling suggested that the former residue affects viral fusion, whereas the latter residue influences the interaction with the viral entry receptor, Niemann-Pick C1.

Journal

  • Journal of General Virology

    Journal of General Virology 99(2), 181-186, 2018-02

    Society for General Microbiology

Codes

  • NII Article ID (NAID)
    120006473697
  • Text Lang
    ENG
  • Article Type
    journal article
  • ISSN
    0022-1317
  • Data Source
    IR 
Page Top